BIIB
Biogen Inc
DRUG MANUFACTURERS - GENERAL · HEALTHCARE
Biogen Inc. is a leading biotechnology firm based in Cambridge, Massachusetts, renowned for its commitment to developing innovative therapies for neurological disorders. Focused on conditions such as multiple sclerosis, Alzheimer's disease, and spinal muscular atrophy, Biogen maintains a robust pipe...
$217.36
+0.10% (+$0.21)
Volume
629,903
52W High
$225.80
52W Low
$135.39
Market Cap
$31.93B
What to Watch This Quarter
Based on historical dataConsensus EPS
$2.31
Whisper EPS
$2.53
9.3% above consensus
Last Quarter
$3.60
Current Streak
8 Beats
Avg Surprise (4Q)
+20.65%
Next Earnings Report
Reports in 43 days
Price Chart
EPS History: Consensus vs Actual
Last 12 quartersPrice Movement Around Earnings
Q2 2026
Jul 29, 2026
1-Day:
-0.62%
5-Day:
-3.54%
Q1 2026
May 6, 2026
1-Day:
+0.37%
5-Day:
+3.81%
Q1 2026
Apr 29, 2026
1-Day:
-2.62%
5-Day:
-3.69%
Q4 2025
Feb 6, 2026
5-Day:
-4.96%
Revenue & Financial Performance
Revenue Whisper
$2.60B
TWN Proprietary Estimate
Last Quarter Revenue
$2.74B
+3.4% YoY
Gross Margin
56.9%
Net Margin: 3.6%
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q2'26 | $2.74B | +3.4% | 56.9% | 11.6% | $97.5M |
| Q1'26 | $2.48B | +1.9% | 73.3% | 16.0% | $319.5M |
| Q4'25 | $2.28B | -7.2% | 78.2% | -2.5% | -$48.4M |
| Q3'25 | $2.45B | -0.5% | 64.3% | 25.0% | $466.5M |
| Q2'25 | $2.65B | +7.3% | 64.2% | 22.2% | $634.8M |
| Q1'25 | $2.43B | +6.1% | 76.2% | 30.1% | $240.5M |
| Q4'24 | $2.45B | +2.9% | 76.2% | 20.7% | $266.7M |
| Q3'24 | $2.47B | -2.6% | 74.1% | 23.4% | $388.5M |
Company Information
Symbol
BIIB
Company
Biogen Inc
Market Cap
$31.93B
Sector
HEALTHCARE
Next Earnings
Oct 29, 2026
Also Reporting Soon
Companies reporting earnings around the same time as BIIB
HEALTHCARE Stocks
Other healthcare companies with earnings data
More in DRUG MANUFACTURERS - GENERAL
Compare BIIB with competitors
Side-by-side earnings comparison